U.S. market Open. Closes in 3 hours 47 minutes

SONN | Sonnet BioTherapeutics Holdings, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 1.4600 - 1.5200
52 Week Range 1.4100 - 18.72
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 48,349
Average Volume 1,356,141
Shares Outstanding 3,007,430
Market Cap 4,390,848
Sector Healthcare
Industry Biotechnology
IPO Date 2006-10-31
Valuation
Profitability
Growth
Health
P/E Ratio -0.13
Forward P/E Ratio N/A
EPS -11.35
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 12
Country USA
Website SONN
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey.
*Chart delayed
Analyzing fundamentals for SONN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see SONN Fundamentals page.

Watching at SONN technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on SONN Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙